Interferon-α activity in a case of severe autoimmune lymphoproliferative disease

Annals of Hematology

Volumn 80, Issue 1, 2001, Pages 49-52

  Ceretelli, S ^a   Petrini, M ^a   Galimberti, S ^a   Testi, C ^a   Frizzera, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Autoimmune lymphoproliferative syndrome; Defective Fas ability; Interferon

Indexed keywords

ALPHA INTERFERON; CD19 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; DNA; FANSIDAR; FAS ANTIGEN; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; RESTRICTION ENDONUCLEASE; STEROID; T LYMPHOCYTE RECEPTOR; UREA;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; FAMILIAL DISEASE; HUMAN; LABORATORY DIAGNOSIS; LEUKOPENIA; LYMPHADENOPATHY; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; REMISSION; SPLENOMEGALY; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; AUTOIMMUNE DISEASES; HUMANS; INTERFERON-ALPHA; LYMPHOPROLIFERATIVE DISORDERS; MALE;

EID: 0035132002     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000228     Document Type: Article

References (17)

1. Structure of the human APO gene
2. Correction of Fas “CD95” deficiency by haploidentical bone marrow transplantation
3. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis
4. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation
5. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity
6. Dominant interfering Fas gene mutations impair apoptosis in a human lymphoproliferative syndrome
7. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity
8. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis
9. Clinical, immunological and pathological consequences of Fas deficient conditions
10. Pathological findings in human autoimmune lymphoproliferative syndrome
11. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse model
12. The Fas death factor
13. Multicentric Castleman's disease
14. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
15. An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome
16. Reversible monoclonal lymphoadenopathy in autoimmune lymphoproliferative syndrome with functional FAS “CD95/APO-1” deficiency
17. The use of the antimalaria drug Fansidar “pyrimetamine and sulphadoxine” in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency